1. Home
  2. KW vs MDXG Comparison

KW vs MDXG Comparison

Compare KW & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • MDXG
  • Stock Information
  • Founded
  • KW 1977
  • MDXG 2006
  • Country
  • KW United States
  • MDXG United States
  • Employees
  • KW N/A
  • MDXG N/A
  • Industry
  • KW Real Estate
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • KW Finance
  • MDXG Health Care
  • Exchange
  • KW Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • KW 940.4M
  • MDXG 877.4M
  • IPO Year
  • KW 1992
  • MDXG N/A
  • Fundamental
  • Price
  • KW $7.60
  • MDXG $7.02
  • Analyst Decision
  • KW Hold
  • MDXG Strong Buy
  • Analyst Count
  • KW 1
  • MDXG 2
  • Target Price
  • KW $13.00
  • MDXG $12.00
  • AVG Volume (30 Days)
  • KW 801.5K
  • MDXG 1.0M
  • Earning Date
  • KW 08-06-2025
  • MDXG 07-30-2025
  • Dividend Yield
  • KW 6.36%
  • MDXG N/A
  • EPS Growth
  • KW N/A
  • MDXG N/A
  • EPS
  • KW N/A
  • MDXG 0.21
  • Revenue
  • KW $543,200,000.00
  • MDXG $363,774,000.00
  • Revenue This Year
  • KW $30.64
  • MDXG $9.55
  • Revenue Next Year
  • KW $3.57
  • MDXG $11.43
  • P/E Ratio
  • KW N/A
  • MDXG $33.21
  • Revenue Growth
  • KW 9.32
  • MDXG 6.85
  • 52 Week Low
  • KW $5.98
  • MDXG $5.47
  • 52 Week High
  • KW $11.88
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • KW 58.64
  • MDXG 55.25
  • Support Level
  • KW $7.22
  • MDXG $6.91
  • Resistance Level
  • KW $7.70
  • MDXG $7.37
  • Average True Range (ATR)
  • KW 0.23
  • MDXG 0.33
  • MACD
  • KW -0.03
  • MDXG 0.02
  • Stochastic Oscillator
  • KW 87.20
  • MDXG 36.18

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: